CAG CONAGRA BRANDS INC.
Food and Kindred Products · NYSE · SEC CIK 23217 · Fiscal year ends 05/30
Financial factors as of 2026-08-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.8%
TTM net income YoY-324.3%
TTM EPS YoY-324.9%
Revenue 3-yr CAGR-2.9%
Net income 3-yr CAGR—
Margins
Gross margin23.8%
Operating margin-15.2%
Net margin-17.0%
FCF margin7.8%
EBITDA margin-11.6%
Returns
ROE-24.9%
ROA-9.8%
ROIC (approx.)-8.9%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets63.8%
Debt / equity1.21x
Current ratio1.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.67x
Accruals ratio-16.4%
Payout ratio—
Capex / revenue3.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-05-31 | FY20252025-05-25 | FY20242024-05-26 | FY20232023-05-28 | FY20222022-05-29 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $11.28B | $11.61B | $12.05B | $12.28B | $11.54B |
| Cost of revenue | $8.58B | $8.61B | $8.72B | $9.01B | $8.70B |
| Gross profit | $2.70B | $3.00B | $3.33B | $3.26B | $2.84B |
| R&D expense | $62.70M | $60.80M | $61.40M | $57.70M | $53.40M |
| SG&A expense | $1.44B | $1.54B | $1.49B | $1.43B | $1.49B |
| Operating income | -$1.63B | $1.36B | $852.80M | $1.08B | $1.59B |
| Pretax income | -$1.82B | $1.16B | $610.20M | $901.90M | $1.18B |
| Income tax | $91.80M | $3.70M | $262.50M | $218.70M | $290.50M |
| Net income | -$1.92B | $1.15B | $347.20M | $683.60M | $888.20M |
| EBITDA | -$1.23B | $1.75B | $1.25B | $1.45B | $1.96B |
| EPS (basic) | -4.00 | 2.41 | 0.73 | 1.43 | 1.85 |
| EPS (diluted) | -4.00 | 2.40 | 0.72 | 1.42 | 1.84 |
| Dividends declared per share | 1.40 | 1.40 | 1.40 | 1.32 | 1.25 |
| Weighted avg. shares (diluted) | 479.00M | 479.70M | 480.00M | 480.70M | 482.20M |
| Banking | |||||
| Net interest income | -$382.60M | -$416.70M | -$430.50M | -$409.60M | -$379.90M |
| Balance sheet | |||||
| Cash & equivalents | $218.00M | $68.00M | $77.70M | $93.30M | $82.20M |
| Receivables | $658.20M | $770.00M | $871.80M | $952.80M | $867.40M |
| Inventory | $1.91B | $2.05B | $1.98B | $2.21B | $1.97B |
| Current assets | $2.88B | $3.07B | $3.15B | $3.38B | $3.03B |
| PP&E, net | $2.86B | $2.83B | $2.82B | $2.74B | $2.74B |
| Goodwill | $8.12B | $10.50B | $10.33B | $10.85B | $11.26B |
| Intangibles | $1.83B | $2.42B | $2.48B | $3.19B | $3.86B |
| Total assets | $17.27B | $20.93B | $20.86B | $22.05B | $22.44B |
| Current liabilities | $3.19B | $4.32B | $3.24B | $4.44B | $3.52B |
| Short-term debt | $34.20M | $1.03B | $20.30M | $1.52B | $707.30M |
| Long-term debt | $7.23B | $6.23B | $7.49B | $7.08B | $8.09B |
| Total debt | $7.26B | $7.26B | $7.51B | $8.60B | $8.80B |
| Total liabilities | $10.92B | $12.00B | $12.35B | $13.25B | $13.57B |
| Shareholders' equity | $6.36B | $8.93B | $8.44B | $8.74B | $8.79B |
| Net debt | $7.05B | $7.19B | $7.44B | $8.50B | $8.71B |
| Cash flow statement | |||||
| Operating cash flow | $1.40B | $1.69B | $2.02B | $995.40M | $1.18B |
| Capital expenditure | $423.40M | $389.30M | $388.10M | $362.20M | $464.40M |
| Free cash flow | $978.70M | $1.30B | $1.63B | $633.20M | $712.90M |
| Investing cash flow | $262.60M | -$542.20M | -$375.00M | -$354.90M | -$434.90M |
| Financing cash flow | -$1.52B | -$1.16B | -$1.66B | -$631.60M | -$738.00M |
| Depreciation & amortization | $396.00M | $390.20M | $400.90M | $369.90M | $375.40M |
| Stock-based compensation | $54.70M | $41.50M | $30.80M | $79.20M | $26.10M |
| Dividends paid | $669.70M | $669.20M | $659.30M | $623.80M | $581.80M |
| Share buybacks | $15.30M | $64.00M | — | $150.00M | $50.00M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.